Altered heme-mediated modulation of dendritic cell function in sickle cell alloimmunization.

Area of Science:

• Immunology
• Hematology
• Cell Biology

Background:

• Sickle cell disease (SCD) patients undergoing transfusions face a high risk of alloimmunization.
• The underlying mechanisms of alloimmunization in SCD are not fully understood.
• Chronic hemolysis in SCD releases free heme, potentially influencing immune responses.

Purpose of the Study:

• To investigate the hypothesis that the anti-inflammatory response to heme is impaired in alloimmunized SCD patients.
• To explore the role of heme in modulating dendritic cell function and T cell priming in SCD patients with and without alloimmunization.

Main Methods:

• Monocyte-derived dendritic cells (moDCs) from healthy donors, non-alloimmunized SCD patients, and alloimmunized SCD patients were exposed to heme.
• Assessed moDC maturation marker CD83 expression and their ability to prime pro-inflammatory CD4(+) type 1 T cells.
• Investigated the involvement of NF-κB signaling and Toll-like receptor 4 (TLR4) in heme-mediated effects.

Main Results:

• Heme inhibited pro-inflammatory CD4(+) T cell priming and reduced CD83 expression on moDCs from healthy donors and non-alloimmunized SCD patients.
• In contrast, heme failed to inhibit T cell priming or moDC maturation in alloimmunized SCD patients.
• Heme-induced NF-κB dampening was observed in non-alloimmunized but not in alloimmunized moDCs; CD83 inhibition was TLR4-dependent.

Conclusions:

• Extracellular heme normally dampens pro-inflammatory responses in non-alloimmunized SCD patients via a TLR4/NF-κB pathway involving moDCs.
• This heme-mediated immune regulation pathway appears defective in alloimmunized SCD patients.
• Understanding this defect offers potential therapeutic targets for preventing alloimmunization in SCD.